Skip to main content
OpenTrials

Clinical trial condition

NASH - Nonalcoholic Steatohepatitis

Explore clinical trials studying NASH - Nonalcoholic Steatohepatitis. Study availability and eligibility vary by location and protocol.

78 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

NASH - Nonalcoholic Steatohepatitis trial results

Active, not recruiting

Nonalcoholic Fatty Liver Disease in HIV Database

NCT05023044

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Indiana University Indianapolis, Indiana, United States
View Trial Details
Active, not recruiting

LITMUS Imaging Study

NCT05479721

Conditions
Digestive System Diseases, Disease, Fatty Liver, +11 more
Locations
  • Pinnacle Clinical Research San Antonio, Texas, United States
  • Helsinki University Hospital Helsinki, Finland
  • Le Centre de Recherche Clinique (CRC) du CHU d'Angers Angers, France
  • Institut ICAN - Institute of Cardiometabolism And Nutrition Hôpital de la Pitié Salpêtrière Paris, France
View all 18 locations
View Trial Details
Completed

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

NCT05232071

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +8 more
Locations
  • Birmingham Digestive Health Research Homewood, Alabama, United States
  • Institute for Liver Health dba Arizona Liver Health Chandler, Arizona, United States
  • ARcare Center for Clinical Research Conway, Arkansas, United States
  • ARcare Center for Clinical Research Little Rock, Arkansas, United States
View all 42 locations
View Trial Details
Completed

Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

NCT04505436

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • North Alabama GI Research Center Huntsville, Alabama, United States
  • Synexus US - Chandler Chandler, Arizona, United States
  • Precision Research Institute, LLC. (PRI) Chula Vista, California, United States
  • Fresno Clinical Research Center Fresno, California, United States
View all 60 locations
View Trial Details
Completed

A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

NCT05039450

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Akero Clinical Study Site Chandler, Arizona, United States
  • Akero Clinical Study Site Glendale, Arizona, United States
  • Akero Clinical Study Site Tucson, Arizona, United States
  • Akero Clinical Study Site Tucson, Arizona, United States
View all 49 locations
View Trial Details

Related conditions